Contraception最新文献

{"title":"Contraceptive use in France by migration background and the role of social deprivation as a mediator: A national cross-sectional study.","authors":"Léa Rouchou, Justine Hugon-Rodin, Camille Le Ray, Valérie Bernard, Elie Azria","doi":"10.1016/j.contraception.2026.111520","DOIUrl":"10.1016/j.contraception.2026.111520","url":null,"abstract":"<p><strong>Background: </strong>Migrant women in high-income countries experience persistent disparities in sexual and reproductive health, including less contraceptive use. The mechanisms underlying these disparities remain insufficiently understood. This study examined the association between migration background and contraceptive use and effectiveness in France and assessed the extent to which social deprivation mediates this relationship.</p><p><strong>Methods: </strong>We analysed data from the 2021 French National Perinatal Survey, a national cross-sectional study including 10,723 women who gave birth in metropolitan France. Contraceptive use before pregnancy planning was classified as effective versus less effective or none. Migration background was defined by geographic region of birth and duration of residence in France. Mediation analysis estimated the proportion of the association mediated by a social deprivation index.</p><p><strong>Results: </strong>The odds of using less effective or no contraception was greater for migrant versus native women (adjusted OR = 2.67; 95%CI [2.41-2.95]). The association was strongest for migrant women residing in France for ≤ 1 year (adjusted OR = 9.28; 95%CI [6.13-14.06]) and decreased with duration of residence. Social deprivation mediated 9.3% (95%CI [6.3-12.3]) of the association between migration background and the use of less effective or no contraception, reaching 21.4% (95%CI[15.8-27.0]) among women born in sub-Saharan Africa.</p><p><strong>Conclusion: </strong>Large disparities in contraceptive use and effectiveness by migration background persist in France and are only partially explained by social deprivation. These findings highlight the influence of structural, cultural, and healthcare system factors beyond socioeconomic vulnerability and underscore the need for culturally responsive and equitable reproductive healthcare policies that address migrant-specific barriers.</p><p><strong>Implications: </strong>Improving contraceptive equity for migrant women requires interventions that extend beyond reducing socioeconomic disadvantage. Policies and healthcare services should strengthen culturally responsive contraceptive counselling, improve access to reproductive healthcare, and address migration-related barriers, particularly for recently arrived women.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111520"},"PeriodicalIF":2.3,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148229661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Informal and out-of-pocket payments for public-sector contraceptive care in remote Madagascar.","authors":"Katherine Tumlinson, Sein Kim, Emilia Goland, Brooke W Bullington, Stephanie Chung, Brian Frizzelle, Eunice Kioko, Ginger Golub, Erica Felker-Kantor, Mickael Randriamanjaka, Andry Rabemanantsoa, Daniel Crapper, Sean Sylvia, Tara Templin","doi":"10.1016/j.contraception.2026.111521","DOIUrl":"10.1016/j.contraception.2026.111521","url":null,"abstract":"<p><strong>Objectives: </strong>Informal payments at public facilities can undermine contraceptive access, yet little is known about how often women pay out of pocket (OOP) for family planning-or how much.</p><p><strong>Study design: </strong>We conducted a descriptive analysis using data collected in 2023 from Alaotra Mangoro, Atsinanana, and Vatovavy Fitovinany in Madagascar. We triangulated: (1) a population-based survey of women aged 15-49 [n = 1199]; analytic subsample: current modern method users who obtained methods in the prior 12 months from public facilities [n = 219] or community health workers (CHWs) [n = 91]; (2) client exit interviews with women seeking contraception at public facilities [n = 118]; (3) CHWs interviews on typical charges [n = 214]; and (4) 107 facility audits. Outcomes were any OOP payment and the amount paid. Population-survey respondents were also asked if any payment was \"unofficial.\"</p><p><strong>Results: </strong>Among facility-sourced users in the population survey, 86% reported paying OOP (median USD 0.56; range 0-1.8). Amounts varied by method (higher for implants, lower for pills). Among CHW-sourced users, 99% paid with amounts broadly similar to facilities overall. In client exit interviews, 53% of clients reported paying, with amounts also lower (median USD 0.11). About 40% of facility-sourced users perceived their payment as unofficial; reports of \"unofficial\" payments were lower among CHW users.</p><p><strong>Conclusions: </strong>Informal payments for contraception appear common and non-trivial in remote Madagascar, despite free-of-charge contraception policy in public-sector facilities. Program responses could include transparent fee charters, strengthened supervision and grievance mechanisms, and routine monitoring of OOP payments across facilities to safeguard contraceptive autonomy.</p><p><strong>Implications: </strong>Informal and out-of-pocket payments create significant financial barriers to family planning, even under free-of-charge contraception policies in public-sector facilities. To ensure equitable access and support contraceptive autonomy, policy efforts should prioritize accountability mechanisms, including standardized fee disclosure, routine verification of client payments, and rigorous supervision of community-level service delivery.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111521"},"PeriodicalIF":2.3,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13498305/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148229673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Consulting OB: How Indiana's abortion ban impacted management of vaginal bleeding in the emergency department.","authors":"Kathryn J LaRoche, Risa Cromer, Andreia Alexander, Brownsyne Tucker Edmonds, Lori Freedman","doi":"10.1016/j.contraception.2026.111519","DOIUrl":"10.1016/j.contraception.2026.111519","url":null,"abstract":"<p><strong>Objectives: </strong>This study examines how Indiana's abortion ban reshaped the provision of care for patients experiencing vaginal bleeding in two emergency medicine sites in the year following implementation.</p><p><strong>Study design: </strong>Between August 2023 and August 2024, we conducted an ethnographic investigation, including observations and semi-structured, in-depth interviews with emergency medicine and OB-GYN clinicians at two clinical sites in Indiana that frequently serve patients with vaginal bleeding. We used a purposive sampling strategy to capture diverse perspectives across clinician types and demographics. Three team members carried out multiple rounds of content and thematic analysis using qualitative data management software, and the full team engaged in iterative discussion to refine interpretation.</p><p><strong>Results: </strong>EM clinicians reported being largely insulated from the ban's effects through increased reliance on a small core of OB clinicians with specialized medical, legal, and socioemotional expertise. EM clinicians increasingly deferred abortion-adjacent care to OB specialists, including referrals, options counseling, and medications for ectopic pregnancy. OB clinicians welcomed expanded consultation roles while noting heightened fear among ED colleagues.</p><p><strong>Conclusion: </strong>Reliance on OB providers appears effective short-term but raises concerns about sustainability, particularly given documented OB-GYN workforce shortages. Over-consultation risks narrowing ED competency with pregnancy-related care, potentially exacerbating barriers to care in rural or resource-limited settings.</p><p><strong>Implications: </strong>In the year following Indiana's abortion ban, EM clinicians at two clinical sites grew reliant on a small core of OB providers, raising concerns about long-term sustainability and ED competency with pregnancy-related care.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111519"},"PeriodicalIF":2.3,"publicationDate":"2026-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148177404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing availability and expanding access to mifepristone at pharmacies in San Diego.","authors":"Karen S Greiner, Sally Rafie, Francesca Selmoni, Anjali Krishnan, Sheila K Mody","doi":"10.1016/j.contraception.2026.111518","DOIUrl":"10.1016/j.contraception.2026.111518","url":null,"abstract":"<p><strong>Objectives: </strong>To determine readiness of pharmacies to dispense mifepristone.</p><p><strong>Study design: </strong>Study team members called pharmacies in San Diego, California. Callers asked standardized questions to determine if the pharmacy was able to dispense mifepristone.</p><p><strong>Results: </strong>Of 153 community and outpatient pharmacies, we reached staff at 149 (97.4%) pharmacies between January 2025 and April 2025. Of these pharmacies, 33 (22.1%) were certified and able to dispense mifepristone, 114 (76.5%) were not, one (0.7%) was unsure, and one (0.7%) was in the process of being certified.</p><p><strong>Conclusions: </strong>Despite the ability of pharmacies to dispense mifepristone since 2023, most pharmacies in San Diego are not yet able to dispense.</p><p><strong>Implications: </strong>Despite policy change in 2023 allowing pharmacies to become certified to dispense mifepristone, this cross-sectional study demonstrates that few pharmacies in San Diego are able to do so, highlighting additional barriers beyond legislative change to patients accessing evidence-based abortion care outside the standard in-person clinic setting.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111518"},"PeriodicalIF":2.3,"publicationDate":"2026-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148195272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Navigating sexual and reproductive health: An analysis of messages sent to a youth-focused textline in Missouri.","authors":"Emma M Gordon, Emma G Garzella, Steph Kraft Sheley, Kathryn J LaRoche","doi":"10.1016/j.contraception.2026.111517","DOIUrl":"10.1016/j.contraception.2026.111517","url":null,"abstract":"<p><strong>Objectives: </strong>We reviewed text messages sent to Right By You (RBY), a Missouri-based, youth-focused reproductive health navigation service that connects texters to care and resources related to abortion, adoption, birth, contraception, and parenting. We aimed to illuminate the specific informational and navigation needs to accessing quality, timely care for abortion, contraception, and pregnancy in Missouri and beyond.</p><p><strong>Study design: </strong>We carried out content and thematic analysis with all anonymized text messages RBY received between April 1, 2022, and October 31, 2023.</p><p><strong>Results: </strong>RBY received texts from 345 unique texters, most of which (n = 210) did not report their age. Seventy-four texters identified themselves as minors under 18 years old. The most common topics asked about were locating a provider and securing funding for abortion care, locating a contraceptive care provider, and accessing contraception without parental involvement. Texters who identified themselves as minors frequently asked questions about navigating the social aspects of scheduling appointments and expressed concerns about privacy. Financial barriers to abortion care were a recurring concern, particularly for minors and people seeking later abortion care.</p><p><strong>Conclusions: </strong>Relying solely on digital resources to share SRH information is inconsistent with the realities of privacy and navigating social interactions raised by texters. Patient navigation services like RBY serve a critical role of real-time navigation support to bridge gaps that the formal systems fail to address.</p><p><strong>Implications: </strong>This study documented a need for personalized, responsive support around appointment scheduling, privacy, and abortion funding, which underscores the importance of tailored health navigation services. Text messaging lines, like Right By You, offer a promising, low-barrier platform to deliver this support in a youth-friendly, confidential manner.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111517"},"PeriodicalIF":2.3,"publicationDate":"2026-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148177428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Changes in beliefs about the safety of clinic-based abortion and self-managed abortion methods in the United States, pre- to post-Dobbs.","authors":"Rosalyn Schroeder, Lauren Ralph, Shelly Kaller, M Antonia Biggs","doi":"10.1016/j.contraception.2026.111515","DOIUrl":"10.1016/j.contraception.2026.111515","url":null,"abstract":"<p><strong>Objective: </strong>To estimate changes in beliefs about abortion safety among a representative sample of the U.S. population assigned female at birth (AFAB) before and after the Supreme Court's 2022 Dobbs decision.</p><p><strong>Study design: </strong>We administered two serial cross-sectional surveys to English- or Spanish-speaking AFAB members of a nationally representative panel (ages 15-49), pre-Dobbs (2021-2022; n = 6943) and post-Dobbs (2023; n = 3533). Respondents indicated their agreement (vs disagree/unsure) that \"it is usually safe\" to end a pregnancy via 1) an in-clinic abortion procedure; and using medication abortion pills obtained 2) at a clinic/doctor's office; or 3) outside the formal healthcare system (for example, from the internet, a friend, etc.). Using adjusted weighted logistic regression models, we assessed changes in safety beliefs pre- to post-Dobbs.</p><p><strong>Results: </strong>From pre- to post-Dobbs, agreeing that each abortion method was \"usually safe\" increased: in-clinic procedural abortion: 57.8-64.1% (p < 0.001); medication abortion from a clinic/doctor's office: 52.2-59.6% (p < 0.001); and medication abortion obtained outside the formal healthcare system: 7.3-9.6% (p = 0.005). Agreement that each abortion method is usually safe increased significantly among respondents identifying as Democrat, with no history of abortion, and/or who support abortion legality (p < 0.05).</p><p><strong>Conclusion: </strong>While abortion restrictions in the U.S. increased, so did public perceptions that procedural and medication abortion are safe. However, about 40% still had concerns about the safety of abortions within the formal healthcare system and almost all (90%) continued to disagree or were unsure whether medication abortion obtained outside the formal healthcare system is safe.</p><p><strong>Implications: </strong>Major gaps exist in the U.S. public's knowledge about abortion safety. These findings suggest that continued education about the availability and safety of medication abortion is essential, particularly as abortion bans and regulatory threats to medication abortion within the formal healthcare system remain and attempts to self-manage increase.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111515"},"PeriodicalIF":2.3,"publicationDate":"2026-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148140238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Out-of-pocket costs for long-acting reversible contraception among individuals enrolled in employer sponsored insurance plans.","authors":"Linda Li, Brittni Frederiksen, Alina Salganicoff","doi":"10.1016/j.contraception.2026.111516","DOIUrl":"10.1016/j.contraception.2026.111516","url":null,"abstract":"<p><strong>Objective: </strong>Recent research finds that a significant share of long-acting reversible contraceptive (LARC) users with private insurance incur out-of-pocket costs associated with contraceptive services and supplies, despite the Affordable Care Act's (ACA) requirement that contraceptives be covered without cost-sharing. This analysis aimed to advance our understanding of what contributes to the out-pocket costs for intrauterine device (IUD) and contraceptive implant insertions by looking at all services and costs associated with insertion among privately insured individuals.</p><p><strong>Study design: </strong>Using the 2023 Merative MarketScan Commercial Claims and Encounter Database, a national sample of healthcare claims for people enrolled in employer sponsored insurance plans, we estimated out-of-pocket costs for 98,916 IUD and 30,259 implant insertion encounters among females ages 15-49.</p><p><strong>Results: </strong>Only 2.4% of IUD and 4.0% of implant insertion encounters had out-of-pocket costs related to the LARC device or insertion procedure itself. However, we find that nearly half of IUD (45.7%) and over a third of implant (35.8%) insertion encounters resulted in out-of-pocket expenses for other services commonly provided as part of a LARC insertion, such as pregnancy tests, office visits, ultrasounds, STI tests, and pain medication. Among insertion encounters with cost-sharing, the median out-of-pocket cost was $35.00 (25^{th -} 75th percentile: $15.00 - $90.00) for an IUD insertion and $16.88 (25^{th -} 75th percentile: $7.75 - $40.00) for an implant insertion.</p><p><strong>Conclusion: </strong>Despite a federal requirement that insurance cover the full cost of contraceptive services and supplies, a sizable share of IUD and contraceptive implant insertions result in out-of-pocket charges for privately insured patients.</p><p><strong>Implications: </strong>While privately insured women rarely pay out-of-pocket for a LARC device or insertion procedure itself, other services commonly provided as part of the LARC insertion often result in out-of-pocket costs, highlighting areas for clearer guidance, stronger oversight, and better patient and provider education on coverage of services related to LARC provision.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111516"},"PeriodicalIF":2.3,"publicationDate":"2026-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148140276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bleeding patterns after replacing versus extending the use of the contraceptive implant at three years of use.","authors":"Sheila K Mody, Gennifer Kully, Marisa C Hildebrand, Sarah Averbach","doi":"10.1016/j.contraception.2026.111514","DOIUrl":"10.1016/j.contraception.2026.111514","url":null,"abstract":"<p><strong>Objectives: </strong>We compared the number of bleeding days among individuals who replaced versus those who extended use of their contraception implant after three years.</p><p><strong>Methods: </strong>Participants reported number of bleeding days for 30 days prior to their 68 mg subdermal etonogestrel implant appointment, decided to replace or extend, and then reported number of bleeding days for 30 days after.</p><p><strong>Results: </strong>Comparing 23 replacers and 29 extenders, we found little difference in point estimates of bleeding days between the two groups (4.0 (IQR 0.0-7.0) and 5.0 (IQR 1.0-7.0), respectively, p = 0.85)).</p><p><strong>Conclusion: </strong>Neither replacing nor extending contraceptive implants at three years of use results in significant bleeding changes in the following 30 days.</p><p><strong>Implications: </strong>Clinicians can counsel patients that short-term bleeding patterns are not expected to change meaningfully when replacing or extended use of contraceptive implant at three years.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"111514"},"PeriodicalIF":2.3,"publicationDate":"2026-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148058629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Society of Family Planning Committee Statement: Telemedicine in family planning care part 1 - Background and overarching principles.","authors":"Rajita Patil, Divya Dethier, Montida Fleming, Emily Godfrey, Julia E Kohn","doi":"10.1016/j.contraception.2025.110914","DOIUrl":"https://doi.org/10.1016/j.contraception.2025.110914","url":null,"abstract":"<p><p>Telemedicine is an effective modality for remote family planning care delivery. Telemedicine increases reach, reduces barriers to care, and facilitates person-centered care. As the demand for telemedicine increases, evidence-based guidance is crucial for optimal practice. This clinical guidance series offers evidence-informed, person-centered, and equity-driven recommendations to enhance telemedicine delivery of contraceptive services and medication abortion in the US. Providing care via telemedicine may not be for everyone, and thus, clinicians should take a person-centered approach to ensure telemedicine meets the needs of the person receiving care. Ensuring that telemedicine remains accessible, regardless of whether a person also requires in-person clinical services, is essential to person-centered family planning care. Telemedicine family planning services should be integrated across practice settings and codesigned with persons from marginalized communities to ensure services are linguistically appropriate, equitable, and accessible. Clinicians should engage in implementation and advocacy efforts that combat health, digital, and structural inequities contributing to disparities in telemedicine family planning care access. Telemedicine family planning care should address the privacy and confidentiality of the person receiving care. Telemedicine family planning care clinicians should be familiar with their state, regional, and institutional laws or regulations regarding abortion care and, more broadly, telemedicine before providing care. Where uncertainty exists, clinicians should consult a lawyer experienced in telemedicine and abortion care. The companion documents, Society of Family Planning Clinical Recommendation: Telemedicine for abortion and contraception part 2 - Contraception and Society of Family Planning Clinical Recommendation: Telemedicine for abortion and contraception part 3 - Abortion, build upon this document and focus on actionable clinical recommendations.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"110914"},"PeriodicalIF":2.3,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147792295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Society of Family Planning Clinical Recommendation: Telemedicine in family planning care part 2 - Contraception.","authors":"Rajita Patil, Divya Dethier, Montida Fleming, Emily Godfrey, Julia E Kohn","doi":"10.1016/j.contraception.2025.110984","DOIUrl":"https://doi.org/10.1016/j.contraception.2025.110984","url":null,"abstract":"<p><p>This Clinical Recommendation provides evidence-informed, person-centered, and equity-driven guidance to optimize contraceptive care via telemedicine in the United States. Recommendations include offering the following contraceptive services via telemedicine: contraceptive counseling, initiation, renewals for methods not requiring procedural placement, and follow-up care for symptoms or complication management not requiring physical exam (GRADE 1B). The person receiving care should have the option to choose their preferred telemedicine service delivery mode, including audio-video, audio-only, or asynchronous care. When prescribing combined hormonal contraceptives (CHCs), we suggest clinicians provide clear guidance on how to remotely collect and report blood pressure measurements, why these data are important, and the availability of alternative contraception options if an unacceptable health risk is identified (GRADE 2C). We recommend prescribing a 1-year supply of CHCs without requiring follow-up within that year unless requested by the person receiving care (GRADE 1A). We recommend progestin-only methods as safe and effective options for telemedicine and self-administered contraception provision (GRADE 1A). We recommend a hybrid approach combining telemedicine and in-person care for long-acting reversible contraception (LARC) methods (GRADE 2B). However, it is important to maintain the option for same-day, in-person LARC provision without requiring prior telemedicine counseling. This document builds upon the Society of Family Planning Committee Statement: Telemedicine in family planning care part 1 - Background and overarching principles and parallels recommendations outlined in the Society of Family Planning Clinical Recommendation: Telemedicine in family planning care part 3 - Abortion. Readers are encouraged to review parts 1 and 3 for this additional context.</p>","PeriodicalId":93955,"journal":{"name":"Contraception","volume":" ","pages":"110984"},"PeriodicalIF":2.3,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147792345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}